Skip to navigation menu Skip to content
Jump to:  A   |   B   |   C   |   D   |   E   |   F   |   G   |   H   |   I   |   J   |   K   |   L   |   M   |   N   |   O   |   P   |   Q   |   R   |   S   |   T   |   U   |   V   |   W   |   X   |   Y

Moderna COVID-19 Vaccine Highly Effective in Kids 12 and Older

Moderna COVID-19 Vaccine Highly Effective in Kids 12 and Older

TUESDAY, May 25, 2021 (HealthDay News) -- Moderna's coronavirus vaccine fully protects children aged 12 to 17, the company announced Tuesday.

In a clinical trial that included more than 3,700 young volunteers, there were no cases of symptomatic COVID-19 infection in the two-thirds of participants who received both doses of the vaccine, which translates into an efficacy rate of 100%.

That's the same rate that was reported recently by Pfizer in clinical trials of its COVID-19 vaccine in 12- to 15-year-olds, The New York Timessaid.

The U.S. Food and Drug Administration's emergency authorization for use of the Moderna vaccine is currently limited to adults, but Moderna said Tuesday that it plans to apply in June for emergency use in adolescents. Pfizer has already been granted that approval for its vaccine.

"We are encouraged that mRNA-1273 [Moderna's vaccine] was highly effective at preventing COVID-19 in adolescents. It is particularly exciting to see that the Moderna COVID-19 vaccine can prevent SARS-CoV-2 infection," Moderna CEO Stéphane Bancel said in a statement. "We will submit these results to the U.S. FDA and regulators globally in early June and request authorization. We remain committed to doing our part to help end the COVID-19 pandemic."

Moderna also noted that a single dose of its vaccine was 93% effective against symptomatic illness.

"Those cases that did occur between the two doses were mild, which is also a good indicator of protection against disease," Saskia Popescu, an infectious disease epidemiologist at George Mason University in Fairfax, Va., told the Times.

Side effects among adolescents who received the Moderna vaccine were similar to those reported in adults: Pain at the injection site, headache, fatigue, muscle pain and chills, the Times reported.

"No significant safety concerns have been identified to date," Moderna said in its statement. Trial participants will be monitored for a year after their second dose.

The trial results were announced in a news release that had no detailed data from the clinical trial, but Moderna said it plans to submit the data for publication in a peer-reviewed journal, the Times reported.

"These look like promising results," Dr. Kristin Oliver, a pediatrician and vaccine expert at Mount Sinai Hospital in New York City, told the Times. "The more vaccines we have to protect adolescents from COVID, the better."

Trials in younger children are ongoing for both Moderna and Pfizer, but results from those could take longer because a safe and effective dose, which could be different than the adult doses, has to first be determined, the Washington Post said.

The strong results the COVID-19 vaccines are showing in teens are helping school officials and local leaders as they plan for the fall. On Monday, Mayor Bill de Blasio said that all public school students in New York City, the largest school system in the United States, would return to in-person learning in the fall.

New York's move came as several states indicated that they will restrict remote learning in the fall, including Connecticut, Illinois, Massachusetts and New Jersey.

More information

Visit the U.S. Centers for Disease Control and Prevention for more on COVID-19 vaccines.

SOURCES: The New York Times; Washington Post; Moderna Inc., news release, May 25, 2021

Reviewed Date: --

Find a pediatrician
Childrens Orthopedics and Sports Medicine
Dr. James Bennett
Dr. J. Marc Cardelia
Dr. Peter Moskal
Dr. Cara Novick
Dr. Carl St. Remy
Sports Medicine
Dr. Joel Brenner
Dr. Aisha Joyce
Dr. Micah Lamb
Dr. David Smith
Infectious Diseases
Dr. Randall Fisher
Dr. Jean Kim
Dr. Laura Sass
Health Tips
Helping Kids Get Over their Fears
When Can a Child Wear Contact Lenses
Immunization Quiz
Teen Health Quiz
Diseases & Conditions
Adolescent (13 to 18 Years)
Amenorrhea in Teens
Anatomy of a Child's Brain
Anatomy of the Endocrine System in Children
Anxiety Disorders in Children
Asthma in Children Index
Becker Muscular Dystrophy (BMD) in Children
Bone Marrow Transplant for Children
Brain Tumors in Children
Breast Conditions in Young Women
Chemotherapy for Children: Side Effects
Ewing Sarcoma in Children
Female Growth and Development
Gynecological and Menstrual Conditions
Hepatitis B Virus (HBV) in Children
High Blood Pressure in Children and Teens
Home Page - Adolescent Medicine
Inflammatory and Infectious Musculoskeletal Disorders
Inflammatory and Infectious Neurological Disorders
Inguinal Hernia in Children
Insect Bites and Children
Kidney Transplantation in Children
Major Depression in Teens
Meningitis in Children
Menstrual Cramps (Dysmenorrhea) in Teens
Menstrual Disorders
Mood Disorders in Children and Adolescents
Myasthenia Gravis (MG) in Children
Oral Health
Osteosarcoma (Osteogenic Sarcoma) in Children
Pap Test for Adolescents
Pediatric Blood Disorders
Posttraumatic Stress Disorder (PTSD) in Children
Preparing the School-Aged Child for Surgery
Schizophrenia in Children
School-Aged Child Nutrition
Sports Safety for Children
Superficial Injuries of the Face and Head- Overview
Teens and Diabetes Mellitus
Television and Children
The Growing Child- Teenager (13 to 18 Years)
The Growing Child: 2-Year-Olds
The Heart
The Kidneys
Your Child's Asthma
Your Child's Asthma: Flare-ups

Disclaimer: This information is not intended to substitute or replace the professional medical advice you receive from your child's physician. The content provided on this page is for informational purposes only, and was not designed to diagnose or treat a health problem or disease. Please consult your child's physician with any questions or concerns you may have regarding a medical condition.